Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
暂无分享,去创建一个
F. Baldanti | L. Cavanna | P. Pedrazzoli | R. Schiavo | E. Percivalle | N. Alessio | A. Sarasini | F. Arena | J. Sammartino | G. Lo Cascio | S. Secondino | I. Cassaniti | G. Comolli | A. Lasagna | F. Agustoni | F. Zavaglio | F. Bergami | A. Ferrari | D. Lilleri | M. Falzoni | S. Borgetto